Emerging Diseases News

Approximately 40% of patients with inflammatory rheumatic disease report adverse physical and mental impacts stemming from the COVID-19 pandemic, according to data published in Clinical Rheumatology.

COVID-19 remained deadlier than influenza this past season, although the difference in mortality shrunk compared with past years, according to a study comparing outcomes of patients hospitalized with the illnesses.

Infants born to people infected with SARS-CoV-2 during pregnancy were five times as likely to test positive for the virus from age 0 to 6 months during the omicron period than previous waves, according to research published in Pediatrics.

Registry data revealed large decreases in the utilization of PCI during the COVID‐19 pandemic, which rebounded quickly by mid-2021.

May 11 will mark the end of the 3-year COVID-19 national public health emergency, as announced earlier this year by President Joe Biden and HHS.

Lower vaccination rates led to a surge in cases of one type of vaccine-derived polio last year, according to a report published Thursday in MMWR.

Treatment with a monoclonal antibody within 2 days of a COVID-19 diagnosis reduced the risk for hospitalization or death by almost 40%, according to a study that assessed patient outcomes over a nearly 2-year period.

The FDA has granted an emergency use authorization for the monoclonal antibody vilobelimab in the treatment of patients with COVID-19 who have undergone ventilation or are on life support, according to a press release from the agency.

Pediatric asthma diagnoses decreased by more than 50% during the first year of the COVID-19 pandemic, according to findings published in Respiratory Research.

Onset of the COVID-19 pandemic was associated with significant increases in postpartum opioid fills, which may lead to increases in adverse outcomes, according to a retrospective cross-sectional study published in JAMA Network Open.